David Scott

Co-Founder & Head of Innovation at Arbor Biotechnologies

David co-founded Arbor Biotechnologies to harness the protein diversity of bacterial and viral genomes for best- or first-in-class biotechnologies to power the next generation of genetic medicines. As Head of Research through May 2021, David led Arbor’s scientific team in the development of the company’s high-throughput discovery engine and the discovery of an industry-leading portfolio of next-generation CRISPR gene editing technologies. Currently, as Head of Innovation, David is focused on growing an ecosystem for the expanded use of Arbor’s technologies and sourcing technologies to accelerate the company’s product development. Prior to Arbor, David completed his PhD at MIT in the lab of Feng Zhang at the Broad Institute, where he explored the early applications of CRISPR systems for genome editing.